Idiopathic short stature (ISS) is a condition characterized by reduced height in children without any obvious causes, such as endocrine disorders, genetic abnormalities, or chronic diseases. This condition can be characterized as a result of a combination of factors, but hereditary factors have a predominant influence. It is important to note that children with IIS have normal physical and cognitive parameters, and their height does not meet the established norm for their age. IIS is often discovered during regular medical examinations, when the child's height is below two standard deviations from the average for his or her age group.
History of the disease and interesting historical facts
The history of idiopathic short stature goes back to the distant past, when short stature began to attract the attention of both medical professionals and the general public. Some of the earliest references to short stature can be found in the works of ancient Greek physicians such as Hippocrates, who attempted to classify diseases based on the physical characteristics of their patients. However, it was not until the early 20th century that systematic studies of short stature began, during which physicians began to identify idiopathic short stature as a separate condition. In the 1960s, the definition and classification of ISD began to be formalized, when scientists such as M. G. Skalozub and V. D. Perelman, among others, conducted intensive research in this area. Ultimately, this led to the understanding that ISD is not a consequence of pathology, but rather an independent syndrome requiring a separate approach to treatment.
Epidemiology
According to various epidemiological studies, the prevalence of idiopathic short stature varies from 1% to 2% in the general population, with these rates varying by region, ethnic group, and social conditions. Studies show that IRS is less common in children with short parents, where the genetic component plays a significant role. In general, IRS occurs in both boys and girls, but some studies have noted a predominance of short boys, which may be due to differences in physiology and genetics. Given modern demographic and social changes related to living conditions and nutrition, these statistics may change.
Genetic predisposition to this disease
Genetic predisposition to idiopathic short stature is becoming an increasingly important topic for study. To date, various groups of genes involved in the regulation of human growth and development have been identified. The first hypotheses about the role of genetic factors in IGR appeared in the 1970s, and since then, numerous studies have been conducted that have confirmed that certain mutations in genes such as GH1, IGF1 and others can lead to growth disorders. For example, studies show that patients with IGR may have polymorphisms in genes such as GHR and IGF1R, which are responsible for susceptibility to insulin-like growth factor. This suggests a multifactorial etiology of the disease, in which both genetic and environmental factors play a significant role.
Risk factors for the development of this disease
Research into risk factors for idiopathic short stature is ongoing, with emphasis on exposure to various physical, chemical, and living conditions. The major risk factors include:
- Heredity: High level of genetic predisposition to growth disorders in parents with short stature.
- Pregnancy problems: complications such as eclampsia or preeclampsia, which result in inadequate nutrition for the fetus.
- Nutritional disorders: lack of essential microelements and vitamins at an early age.
- Chronic illnesses: presence of infections or other diseases that may affect growth rate.
- Environmental factors: Exposure to toxic substances such as lead, which can interfere with normal development.
Diagnosis of this disease
The diagnosis of idiopathic short stature involves a wide range of methods aimed at identifying the causes of short stature and ruling out other diseases. The main symptoms usually include a significant delay in growth compared to peers, up to two standard deviations. Laboratory tests may include:
- Hormone tests: assess levels of growth hormone and insulin-like growth factor.
- Genetic testing: detects possible mutations in genes related to growth.
- Blood tests: Determine your overall health, including vitamin and mineral levels.
Radiological tests may include X-rays to assess bone age. Other diagnostics may include endocrine tests and thyroid ultrasound. Differential diagnosis is important to rule out other conditions, such as hormonal imbalances and genetic syndromes.
Treatment
Depending on the cause and severity of idiopathic short stature, the approach to treatment may vary. General treatment involves monitoring the child’s growth and well-being, as well as supporting their physical and emotional development. Pharmacological treatment may include the use of growth hormones, and particular attention is paid to the initiation of therapy, as early intervention can significantly improve outcomes. Surgical treatment is not widely used in this context, but operations to correct specific skeletal deformities are possible. In addition, a special diet or vitamin and mineral supplements may be prescribed to improve nutrition.
List of medications used to treat this disease
In therapeutic practice, the following drugs can be used to treat idiopathic short stature:
- Recombinant growth hormone (Somatropin)
- Insulin-like growth factor (IGF-1)
- Vitamin and mineral supplements (calcium, vitamin D)
Disease monitoring
Monitoring the condition of a child with idiopathic short stature plays an important role in timely treatment adjustments and prognosis assessment. Control stages should include regular measurements of height and weight, laboratory tests, and assessment of the response to therapy. The prognosis may vary, but most children with IRD achieve normal growth with adequate treatment. Complications typically include psychological problems related to the child’s social adaptation and self-perception.
Age-related features of the disease
Idiopathic short stature can present differently depending on the age group. In newborns and infants, symptoms may be unreadable, but with age, growth retardation becomes more pronounced. In adolescents, ISD can impede the development of secondary sexual characteristics and cause problems with self-esteem and social integration. In adulthood, consequences can include musculoskeletal disorders and a variety of metabolic disorders.
Questions and Answers
- What is idiopathic short stature? It is a condition characterized by short stature without obvious causes such as genetic abnormalities or endocrine disorders.
- What are the main causes of idiopathic short stature? The causes are considered to be genetic factors, environmental influences, nutrition and the presence of chronic diseases.
- How is this disease diagnosed? Diagnosis includes laboratory tests of hormones, genetic tests and radiological examinations.
- What treatment is needed for children with IRR? Treatment may include growth hormone therapy, nutritional modifications, and psychological support.
- What is the prognosis for children with idiopathic short stature? Usually, with adequate treatment, children achieve normal growth, but regular monitoring is important.
Advice from Dr. Oleg Korzhikov
When treating idiopathic short stature, it is important to remember the following recommendations:
- Have regular check-ups with your pediatrician and endocrinologist.
- Ensure a balanced diet to maintain overall health.
- Support your child's psycho-emotional state by providing him with the opportunity to participate in social activities.
- If necessary, begin growth hormone treatment as early as possible to maximize results.
